BioMarin Announces Proposed Private Offering of $500 Million of Senior Subordinated Convertible Notes

SAN RAFAEL, CA (STL.News) BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that it intends to offer,…